Progesterone receptor and dopamine receptors are required in Δ9-tetrahydrocannabinol modulation of sexual receptivity in female rats
-
Contributed by Bert W. O'Malley
Abstract
Ovarian steroids, estrogen and progesterone, influence the sensitivity of certain neural processes to cannabinoid treatment by modulation of brain dopaminergic activity. We examined the effects of the active ingredient of cannabis, Δ9-tetrahydrocannabinol (THC), on sexual behavior in female rats and its influence on steroid hormone receptors and neurotransmitters in the facilitation of sexual receptivity. Our results revealed that the facilitatory effect of THC was inhibited by antagonists to both progesterone and dopamine D1 receptors. To test further the idea that progesterone receptors (PR) and/or dopamine receptors (D1R) in the hypothalamus are required for THC-facilitated sexual behavior in rodents, antisense and sense oligonucleotides to PR and D1R were administered intracerebroventricularly (ICV) into the third cerebral ventricle of ovariectomized, estradiol benzoate-primed rats. Progesterone- and THC-facilitated sexual behavior was inhibited in animals treated with antisense oligonucleotides to PR or to D1R. Antagonists to cannabinoid receptor-1 subtype (CB1), but not to cannabinoid receptor-2 subtype (CB2) inhibited progesterone- and dopamine-facilitated sexual receptivity in female rats. Our studies indicate that THC acts on the CB1 cannabinoid receptor to initiate a signal transduction response that requires both membrane dopamine and intracellular progesterone receptors for effective induction of sexual behavior.
Footnotes
-
↵ * To whom reprint requests should be addressed. E-mail: smani{at}bcm.tmc.edu.
-
See commentary on page 793.
-
Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073/pnas.031563998.
-
Article and publication date are at www.pnas.org/cgi/doi/10.1073/pnas.031563998
- Abbreviations:
- THC,
- Δ9-tetrahydrocannabinol;
- LH,
- luteinizing hormone;
- CB,
- cannabinoid;
- E,
- estrogen;
- P,
- progesterone;
- PR,
- P receptor;
- CB1,
- CB receptor-1 subtype;
- EB,
- estradiol benzoate;
- LQ,
- lordosis quotient;
- ICV,
- intracerebroventricular;
- MAPK,
- mitogen-activated protein kinase
- Copyright © 2001, The National Academy of Sciences





